Stay updated on Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.

Latest updates to the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Locations section with Texas as a study site and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure and the Texas Locations item.SummaryDifference0.2%

- Check21 days agoChange DetectedRemoved related topics 'Prostate Cancer' and 'MedlinePlus Genetics' from the MedlinePlus related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedProstate cancer is added as a related topic, and MedlinePlus Genetics is included as a related topic.SummaryDifference0.2%

- Check35 days agoChange DetectedRemoved the 'Prostate cancer' item and the 'MedlinePlus Genetics' related topic from the page's Related Topics section. This is a minor, non-critical update to supplementary navigation that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Prostate cancer and related MedlinePlus Genetics topics, and updated the page revision from v3.2.0 to v3.3.2.SummaryDifference0.2%

- Check49 days agoChange DetectedThe government funding status banner on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib And Androgen Ablation in Prostate Cancer Clinical Trial page.